Growth Boost Series

Anthropic IPO Tranche B — Staged Sale

A predefined strategy designed to pursue sales at three progressively higher price levels.

Interested in the Anthropic IPO GrowthBoost Series?

For more information about the available investment strategies, eligibility requirements or participation process, please contact your Candour representative or our Structured Investment team.

We can guide you through the product features, settlement options, key dates and associated risks to help you make an informed investment decision.

Available to eligible Australian resident wholesale investors only.
Contact Us
info [at] candourcapital.com
Important Information
Terms & Conditions Information Memorandum Term Sheet Information Memorandum

Three Target Sale Levels | +10%, +20%, +30% | Structured Exit Strategy

Candour's GrowthBoost Anthropic IPO Staged Sale is a short-term Deferred Purchase Agreement designed to provide exposure to Anthropic's proposed Nasdaq listing while pursuing a staged sale strategy.

The structure targets the sale of approximately one-third of the initial reference share quantity at each of three price levels: 10%, 20% and 30% above the actual IPO acquisition price.

Sales are attempted only during the designated Sale Window. Any shares not sold remain part of the investor's exposure, and the final settlement depends on actual executed sales and the applicable settlement election.
Three Predefined Sale Targets:

Target levels set at 110%, 120% and 130% of the IPO acquisition price.

Staged Sale Strategy

Approximately one-third of the initial reference quantity is assigned to each target.

Short-Term Strategy Window

Sale orders may be executed during the specified Nasdaq trading sessions from 23–27 November 2026.

Flexible Settlement Election

Receive a calculated physical share parcel by default, or elect cash for realised sale value with remaining exposure delivered in shares.

Continued Share Exposure

Shares not sold during the Sale Window remain economically exposed to Anthropic's share price.

How It Works

The structure uses three sale targets based on the actual IPO acquisition price, P0.

Image 20261112150657 84 33

At the end of the Sale Window, two settlement options apply:

  • Default – Physical Delivery: Net realised strategy sale proceeds are used to calculate additional delivery shares at the applicable maturity reference price. These are combined with remaining unsold exposure and delivered as a share parcel, with any rounding cash paid separately.
  • Optional – Cash and Shares: Under a valid Series Sales Agency Agreement, investors receive the net realised sale value in AUD, while remaining unsold exposure is delivered physically in shares.

No sale is assumed merely because a target price is reached. Only completed executions are included.

Product Terms

Reference Asset

Anthropic, PBC Class A Common Stock

Proposed Listing

Nasdaq Global Select Market (ANT)

Subscription Currency

AUD

Investment Term

1 week

Scheduled Issue Date

23 November 2026

Sale Targets

+10%, +20%, +30%

Sale Allocation

Approximately one-third per level

Sale Window

From actual Nasdaq trading commencement, subject to confirmed allocation and broker sale availability, until 1pm New York time on 27 November 2026. Commercially reasonable efforts apply; execution is not guaranteed.

Sale Window Closes

27 November, 1:00 pm New York time

Maturity Date

30 November 2026

Cash Election Deadline

30 November 2026, 5:00 pm Sydney time

Settlement

Shares by default; optional realised-value cash plus remaining shares

Final Settlement

Within 30 Australian Business Days after Maturity, subject to Settlement Disruption

Application Closing Date

Friday 13 November 2026, close of business (Sydney time)

Cleared Funds Deadline

Monday 16 November 2026 (Sydney time)

Issuer

Candour Structured Investment Pty Ltd

Unallocated Cash

Unallocated cash is returned at final settlement with the shares and any elected cash entitlement, after authorised deductions.

Why Consider This Structure
Important Considerations

Deferred Purchase Agreement